Literature DB >> 1783916

Acute treatment of myasthenia gravis with intranasal neostigmine: clinical and electromyographic evaluation.

R Ricciardi1, B Rossi, M Nicora, A Sghirlanzoni, A Muratorio.   

Abstract

The effectiveness of intranasal neostigmine (9.3-13.8 mg) was tested in 20 subjects with myasthenia gravis, classified as Osserman grades 2A and 2B. In all cases the drug produced significant clinical and electromyographic improvement. No side effects were reported during the treatment.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1783916      PMCID： PMC1014678          DOI： 10.1136/jnnp.54.12.1061

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  5 in total

1.  Effect of bile salts on nasal permeability in vitro.

Authors:  S J Hersey; R T Jackson
Journal:  J Pharm Sci       Date:  1987-12       Impact factor: 3.534

2.  Electrical and mechanical responses of normal and myasthenic muscle.

Authors:  A Slomić; A Rosenfalck; F Buchthal
Journal:  Brain Res       Date:  1968-08-05       Impact factor: 3.252

3.  Electrical testing in myasthenia gravis.

Authors:  C Ozdemir; R R Young
Journal:  Ann N Y Acad Sci       Date:  1971-09-15       Impact factor: 5.691

4.  Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis.

Authors:  R Mantegazza; C Antozzi; D Peluchetti; A Sghirlanzoni; F Cornelio
Journal:  J Neurol       Date:  1988-11       Impact factor: 4.849

5.  Topical therapy for oropharyngeal symptoms of myasthenia gravis.

Authors:  J M Dooley; K J Goulden; J G Gatien; E J Gibson; B S Brown
Journal:  Ann Neurol       Date:  1986-02       Impact factor: 10.422
  5 in total
  6 in total

1.  Endoscopic thymectomy: a neurologist's perspective.

Authors:  Roberta Ricciardi; Franca Melfi; Michelangelo Maestri; Anna De Rosa; Afroditi Petsa; Marco Lucchi; Alfredo Mussi
Journal:  Ann Cardiothorac Surg       Date:  2016-01

Review 2.  A practical guide to the recognition and management of myasthenia gravis.

Authors:  A Evoli; A P Batocchi; P Tonali
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

3.  Intramuscular neostigmine and glycopyrrolate safely accelerated bowel evacuation in patients with spinal cord injury and defecatory disorders.

Authors:  Alan S Rosman; Geeta Chaparala; Amit Monga; Ann M Spungen; William A Bauman; Mark A Korsten
Journal:  Dig Dis Sci       Date:  2008-03-13       Impact factor: 3.199

4.  Early Treatment with Intranasal Neostigmine Reduces Mortality in a Mouse Model of Naja naja (Indian Cobra) Envenomation.

Authors:  Matthew R Lewin; Stephen P Samuel; David S Wexler; Philip Bickler; Sakthivel Vaiyapuri; Brett D Mensh
Journal:  J Trop Med       Date:  2014-05-14

5.  Reversal of experimental paralysis in a human by intranasal neostigmine aerosol suggests a novel approach to the early treatment of neurotoxic envenomation.

Authors:  Matthew R Lewin; Philip Bickler; Tom Heier; John Feiner; Lance Montauk; Brett Mensh
Journal:  Clin Case Rep       Date:  2013-07-24

6.  Charge Transfer Complex of Neostigmine with 2,3-Dichloro-5,6-Dicyano-1,4-Benzoquinone: Synthesis, Spectroscopic Characterization, Antimicrobial Activity, and Theoretical Study.

Authors:  Tarek A Yousef; Essam Ezzeldin; Hatem A Abdel-Aziz; Mohamed H Al-Agamy; Gamal A E Mostafa
Journal:  Drug Des Devel Ther       Date:  2020-10-06       Impact factor: 4.162
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.